NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation. Investors have until December 13, 2 ...

SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024. Edwards is an international company that researches, develops, and provides products and technologies for heart valve repair and replacement therapies, as well as critical care monitoring solutions. For more information, submit a form, ...

LOS ANGELES, Oct. 21, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE: EW) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive ...

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Edwards Lifesciences Corporation (NYSE: EW)?Did you purchase your shares between February 6, 2024 and July 24, 2024, inclusive?Did you lose money in your investment in Edwards Lifesciences Corporation?Do you want to discuss your rights? Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Edwards Lifesciences Corporation (“Edwards” or the “Company”) (NYSE: EW) investors of an upc ...

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation. Investors have until December 13, 2 ...

文章核心观点 - 爱德华兹生命科学公司(Edwards Lifesciences)在2024年2月6日至7月24日期间,向投资者提供了虚假或误导性的信息,隐瞒了其主要产品TAVR(经导管主动脉瓣置换)的收入预期下滑情况 [3][4] - 2024年7月24日,公司公布了低于预期的第二季度财务业绩,并大幅下调了全年TAVR收入指引,导致股价大跌约31.34% [4] - 公司声称TAVR业务受到新兴治疗方式(如TMTT)的挤压,使医院心脏结构团队资源受限,无法充分利用TAVR [4] - 公司在第二季度宣布了三项收购,表明其意识到TAVR增长放缓的风险 [4] 公司概况 - 爱德华兹生命科学公司是一家专注于心脏疾病治疗的医疗器械公司,主要产品为TAVR [3] - 公司在2024年2月6日至7月24日期间,向投资者提供了虚假或误导性信息 [3] - 公司在2024年7月24日公布了低于预期的财务业绩,并大幅下调了TAVR全年收入指引 [4] 行业动态 - 公司表示TAVR业务受到新兴治疗方式(如TMTT)的挤压,使医院心脏结构团队资源受限,无法充分利用TAVR [4] - 公司在第二季度宣布了三项收购,表明其意识到TAVR增长放缓的风险 [4]

SAN DIEGO, Oct. 19, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, both dates inclusive (the "Class Period"), have until December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v. Edwards Lifesciences Corporation, No. 24-cv-02221 (C.D. Cal.), the Edwards Lifesciences class action lawsuit charg ...

NEW YORK, Oct. 19, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation. Investors have until December 13, 2 ...

RADNOR, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Edwards Lifesciences Corporation ("Edwards") (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is Dece ...

NEW YORK, Oct. 17, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the "Class Period"). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 13, 2024. So what: If you purchased Edwards Lifesciences Corporation se ...